Optimal design of studies of influenza transmission in households. I: Case-ascertained studies

Epidemiology and Infection

Volumn 140, Issue 1, 2012, Pages 106-114

  Klick, B ^a   Leung, G M ^a   Cowling, B J ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Epidemiology; virus infection

Indexed keywords

ARTICLE; CASE STUDY; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; FOLLOW UP; HOME CARE; HOUSEHOLD; INFLUENZA; INTERMETHOD COMPARISON; SAMPLE SIZE; SELF REPORT; STUDY DESIGN; VIRUS TRANSMISSION;

COMPUTER SIMULATION; DATA COLLECTION; EPIDEMIOLOGIC RESEARCH DESIGN; FAMILY CHARACTERISTICS; HUMANS; INFLUENZA, HUMAN; MODELS, THEORETICAL; ODDS RATIO; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; VIRUS SHEDDING;

EID: 82455187800     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268811000392     Document Type: Article

References (40)

1. Carrat F, et al. Influenza burden of illness: estimates from a national prospective survey of household contacts in France. Archives of Internal Medicine 2002; 162: 1842-1848.
2. Ferguson NM, et al. Strategies for mitigating an influenza pandemic. Nature 2006; 442: 448-452. (Pubitemid 44264793)
3. Monto AS, Koopman JS, Longini Jr. IM. Tecumseh study of illness. XIII. Influenza infection and disease, 1976-1981. American Journal of Epidemiology 1985; 121: 811-822. (Pubitemid 15028257)
4. Hayden FG, et al. Inhaled zanamivir for the prevention of influenza in families. Zanamivir Family Study Group. New England Journal of Medicine 2000; 343: 1282-1289.
5. Monto AS, et al. Zanamivir prophylaxis: an effective strategy for the prevention of influenza types A and B within households. Journal of Infectious Diseases 2002; 186: 1582-1588. (Pubitemid 35379634)
6. Hayden FG, et al. Management of influenza in households: a prospective, randomized comparison of oseltamivir treatment with or without postexposure prophylaxis. Journal of Infectious Diseases 2004; 189: 440-449. (Pubitemid 38210580)
7. Welliver R, et al. Effectiveness of oseltamivir in preventing influenza in household contacts: a randomized controlled trial. Journal of the American Medical Association 2001; 285: 748-574.
8. van Boven M, et al. Transmission of novel influenza A(H1N1) in households with post-exposure antiviral prophylaxis. PLoS One 2010; 5: e11442.
9. Cowling BJ, et al. Preliminary findings of a randomized trial of non-pharmaceutical interventions to prevent influenza transmission in households. PLoS One 2008; 3: e2101.
10. Cowling BJ, et al. Facemasks and hand hygiene to prevent influenza transmission in households: a cluster randomized trial. Annals of Internal Medicine 2009; 151: 437-446.
11. Simmerman JM, et al. Findings from a household randomized controlled trial of hand washing and face masks to reduce influenza transmission in Bangkok, Thailand. Influenza and Other Respiratory Viruses (in press).
12. MacIntyre CR, et al. Face mask use and control of respiratory virus transmission in households. Emerging Infectious Diseases 2009; 15: 233-241.
13. Canini L, et al. Surgical mask to prevent influenza transmission in households: a cluster randomized trial. PLoS One 2010; 5: e13998.
14. Viboud C, et al. Risk factors of influenza transmission in households. British Journal of General Practice 2004; 54: 684-689. (Pubitemid 39232525)
15. Cauchemez S, et al. Household transmission of 2009 pandemic influenza A (H1N1) virus in the United States. New England Journal of Medicine 2009; 361: 2619-2627.
16. France AM, et al. Household transmission of 2009 influenza A (H1N1) virus after a school-based outbreak in New York City, April-May 2009. Journal of Infectious Diseases 2010; 201: 984-992.
17. Looker C, et al. Influenza A (H1N1) in Victoria, Australia: a community case series and analysis of household transmission. PLoS One 2010; 5: e13702.
18. Doyle TJ, Hopkins RS. Low secondary transmission of 2009 pandemic influenza A (H1N1) in households following an outbreak at a summer camp: relationship to timing of exposure. Epidemiology and Infection 2010; 139: 45-51.
19. Papenburg J, et al. Household transmission of the 2009 pandemic A/H1N1 influenza virus: elevated laboratoryconfirmed secondary attack rates and evidence of asymptomatic infections. Clinical Infectious Diseases 2010; 51: 1033-1041.
20. Morgan OW, et al. Household transmission of pandemic (H1N1) 2009, San Antonio, Texas, USA, April-May 2009. Emerging Infectious Diseases 2010; 16: 631-637.
21. Cowling BJ, et al. Comparative epidemiology of pandemic and seasonal influenza A in households. New England Journal of Medicine 2010; 362: 2175-2184.
22. Suess T, et al. Shedding and transmission of novel influenza virus A/H1N1 infection in households - Germany, 2009. American Journal of Epidemiology 2010; 171: 1157-1164.
23. Monto AS, Koopman JS, Bryan ER. The Tecumseh Study of Illness. XIV. Occurrence of respiratory viruses, 1976-1981. American Journal of Epidemiology 1986; 124: 359-367. (Pubitemid 16047352)
24. Yang Y, Longini Jr. IM, Halloran ME. Design and Evaluation of Prophylactic Interventions Using Infectious Disease Incidence Data from Close Contact Groups. Journal of the Royal Statistical Society Series C (Applied Statistics) 2006; 55: 317-330. (Pubitemid 43536589)
25. Hurt AC, et al. Performance of six influenza rapid tests in detecting human influenza in clinical specimens. Journal of Clinical Virology 2007; 39: 132-135. (Pubitemid 46777422)
26. Sikora C, et al. Transmission of pandemic influenza A (H1N1) 2009 within households: Edmonton, Canada. Journal of Clinical Virology 2010; 49: 90-93.
27. Call SA, et al. Does this patient have influenza? Journal of the American Medical Association 2005; 293: 987-997. (Pubitemid 40271131)
28. Lau LL, et al. Viral shedding and clinical illness in naturally acquired influenza virus infections. Journal of Infectious Diseases 2010; 201: 1509-1516.
29. Diggle P. Analysis of Longitudinal Data, 2nd edn. Oxford, New York: Oxford University Press, 2002, pp. xv, 379.
30. Moineddin R, Matheson FI, Glazier RH. A simulation study of sample size for multilevel logistic regression models. BMC Medical Research Methodology 2007; 7: 34.
31. Ferguson NM, et al. Strategies for containing an emerging influenza pandemic in Southeast Asia. Nature 2005; 437: 209-214. (Pubitemid 41294478)
32. White LF, et al. Estimation of the reproductive number and the serial interval in early phase of the 2009 influenza A/H1N1 pandemic in the USA. Influenza and Other Respiratory Viruses 2009; 3: 267-276.
33. Cowling BJ, et al. Estimation of the serial interval of influenza. Epidemiology 2009; 20: 344-347.
34. Vickers A. How many repeated measures in repeated measures designs ? Statistical issues for comparative trials. BMC Medical Research Methodology 2003; 3: 22.
35. Bloch DA. Sample size requirements and the cost of a randomized clinical trial with repeated measurements. Statistics in Medicine 1986; 5: 663-667. (Pubitemid 17220060)
36. Lui KJ, Cumberland WG. Sample size requirement for repeated measurements in continuous data. Statistics in Medicine 1992; 11: 633-641.
37. Winkens B, et al. Optimal number of repeated measures and group sizes in clinical trials with linearly divergent treatment effects. Contemporary Clinical Trials 2006; 27: 57-69. (Pubitemid 41758439)
38. Cook AR, Gibson GJ, Gilligan CA. Optimal observation times in experimental epidemic processes. Biometrics 2008; 64: 860-868.
39. Okiro EA, et al. Duration of shedding of respiratory syncytial virus in a community study of Kenyan children. BMC Infectious Disease 2010; 10: 15.
40. Carrat F, et al. Time lines of infection and disease in human influenza: a review of volunteer challenge studies. American Journal of Epidemiology 2008; 167: 775-785. (Pubitemid 351451744)